Novartis faces third clinical-trial setback in a week as muscle drug fails ...Middle East

The medicine, called del-desiran, was the centerpiece of Novartis's $12 billion takeover of Avidity Biosciences and touted as a potential blockbuster

Hence then, the article about novartis faces third clinical trial setback in a week as muscle drug fails was published today ( Tuesday 08/09/2026 - 10:54 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novartis faces third clinical-trial setback in a week as muscle drug fails )

Also on site :

• China Merchants Bank Wins CNCF End User Case Study Contest for Unifying AI Training and Inference on Kubernetes
• STRADVISION Brings AI Vision Perception Expertise to Arm Total Design for Physical AI and Robotics Capability Framework Initiative
• New York’s Nuclear Comeback Is Gathering Steam